BB vs MNPR · P/E 117, rev $549.1M vs $431.4M cap
BlackBerry Ltd (BB) versus Monopar Therapeutics Inc (MNPR) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Latest reported MNPR revenue for 2024-12-31 was $0. Net income was -$15.6M. MNPR currently screens at market cap $431.4M.
BB currently screens at market cap $6.14B and trailing P/E 116.5. MNPR currently screens at market cap $431.4M.
Not investment advice. Open the BB and MNPR stock pages for the full models.
Not investment advice.